Article

UFC Statement on Gilbert Melendez

Following his bout at UFC 188 in Mexico City on June 13, UFC lightweight Gilbert Melendez tested positive for exogenous origin of testosterone metabolites. The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by our athletes. As a result of the positive test, Melendez has accepted a one-year suspension, effective from the date of the bout, for violating the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC.

“Regrettably, I tested positive in my post fight urine sample for UFC 188,” Melendez said. “I did not inject anything, but I am responsible and accept the consequences for the results.  I will make sure I am better educated about the products I use and their implications. Going forward I will ensure no products I use will contain banned substances. I am sincerely apologetic to everyone who supports me, including my fans, sponsors and the UFC.  I value your trust and respect and will do everything in my power to keep it.”

Melendez will no longer compete as scheduled on July 15. UFC officials are currently seeking a new opponent for Al Iaquinta, who was scheduled to face Melendez.

Watch Past Fights

Sunday, May 27
7PM
CEST
Liverpool, United Kingdom

Media

Recent
Darren Till continues his quest to be the greatest with a main event matchup against Stephen Thompson this Sunday in Liverpool.
May 22, 2018
The co-main event at UFC 225 in Chicago features an interim welterweight title fight between former lightweight champion Rafael Dos Anjos and Colby Covington.
May 22, 2018
Darren Till showed that he was a true contender with an impressive performance against Donald "Cowboy" Cerrone last year in Gdansk, Poland. Till faces former title challenger Stephen Thompson in the main event of Fight Night Liverpool on Sunday, May 27.
May 22, 2018
A rematch between middleweight champion Robert Whittaker and Yoel Romero is set to headline UFC 225 in Chicago on June 9 live on Pay-Per-View.
May 22, 2018